(Q38410465)

English

Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial

scientific article published on June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial (English)

1 reference

Europe PubMed Central

2 September 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Paul Hartley

1

1 reference

Europe PubMed Central

2 September 2017

Yue Shentu

2

1 reference

Europe PubMed Central

2 September 2017

Patricia Betz-Schiff

3

1 reference

Europe PubMed Central

2 September 2017

Gregory T Golm

4

1 reference

Europe PubMed Central

2 September 2017

Christine McCrary Sisk

5

1 reference

Europe PubMed Central

2 September 2017

Samuel S Engel

6

1 reference

Europe PubMed Central

2 September 2017

R Ravi Shankar

7

1 reference

Europe PubMed Central

2 September 2017

publication date

1 June 2015

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

32

1 reference

Europe PubMed Central

2 September 2017

6

1 reference

Europe PubMed Central

2 September 2017

469-476

1 reference

Europe PubMed Central

2 September 2017

https://scigraph.springernature.com/pub.10.1007/s40266-015-0271-z

0 references

The burden and treatment of diabetes in elderly individuals in the u.s.

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Management of type 2 diabetes mellitus in the elderly: special considerations

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Hypoglycaemia in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

The impact of recurrent hypoglycemia on cognitive function in aging

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

The durability of sitagliptin in elderly patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Comparative analysis of two rates

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Contraindications can damage your health--is metformin a case in point?

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0271-Z

21 January 2018

Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26041585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26041585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26041585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus in the elderly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26041585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoglycemia in hospitalized patients treated with sulfonylureas

1 reference

https://pubmed.ncbi.nlm.nih.gov/26041585

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40266-015-0271-Z

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38410465&oldid=1757956390"